Skip to main content
European Commission logo print header

The potential and application of virus host evasion genes that modify apoptosis and cytokine responses

Objectif

The aim is to identify and exploit viral modifiers of apoptosis and cytokine responses (particularly Toners) as a potential source of novel health care pharmaceuticals for manipulation of immune responses and treatment of certain diseases. Such virus genes will be identified by nucleotide sequence and functional analysis of cloned viral Orbs and coda libraries of three large DNA viruses (African swine fever, Extremely and Mouse herpes). Possible human homologue of novel sequences will be characterised. The cellular targets of these viral evasion genes and their impact on apoptosis and virus pathogenesis will be determined. Determination of minimal active sequences will permit the development of low molecular weight peptide drugs, starting with the calcineurin phosphates inhibitor A238L gene of ASFV.

Appel à propositions

Data not available

Régime de financement

CSC - Cost-sharing contracts

Coordinateur

FUNDACAO CALOUSTE GULBENKIAN
Contribution de l’UE
Aucune donnée
Adresse
6,Rua da Quinta Grande n°6
2780-156 OEIRAS
Portugal

Voir sur la carte

Coût total
Aucune donnée

Participants (3)